These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37573446)

  • 1. An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients.
    Ferrández MC; Golla SSV; Eertink JJ; de Vries BM; Lugtenburg PJ; Wiegers SE; Zwezerijnen GJC; Pieplenbosch S; Kurch L; Hüttmann A; Hanoun C; Dührsen U; de Vet HCW; ; Zijlstra JM; Boellaard R
    Sci Rep; 2023 Aug; 13(1):13111. PubMed ID: 37573446
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Girum KB; Rebaud L; Cottereau AS; Meignan M; Clerc J; Vercellino L; Casasnovas O; Morschhauser F; Thieblemont C; Buvat I
    J Nucl Med; 2022 Dec; 63(12):1925-1932. PubMed ID: 35710733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
    Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Cui Y; Jiang Y; Deng X; Long W; Liu B; Fan W; Li Y; Zhang X
    Acad Radiol; 2023 Jul; 30(7):1408-1418. PubMed ID: 36437191
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Eertink JJ; van de Brug T; Wiegers SE; Zwezerijnen GJC; Pfaehler EAG; Lugtenburg PJ; van der Holt B; de Vet HCW; Hoekstra OS; Boellaard R; Zijlstra JM
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):932-942. PubMed ID: 34405277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of Dmax and %ΔSUVmax of
    Dang J; Peng X; Wu P; Yao Y; Tan X; Ye Z; Jiang X; Jiang X; Liu Y; Chen S; Cheng Z
    BMC Med Imaging; 2023 Oct; 23(1):173. PubMed ID: 37907837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of metabolic tumour volume on baseline
    Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments.
    Jemaa S; Paulson JN; Hutchings M; Kostakoglu L; Trotman J; Tracy S; de Crespigny A; Carano RAD; El-Galaly TC; Nielsen TG; Bengtsson T
    Cancer Imaging; 2022 Aug; 22(1):39. PubMed ID: 35962459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
    Ding CY; Guo Z; Sun J; Yang WP; Li TR
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic analysis of interim
    Yuan L; Kreissl MC; Su L; Wu Z; Hacker M; Liu J; Zhang X; Bo Y; Zhang H; Li X; Li S
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):478-488. PubMed ID: 30382301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma.
    Eertink JJ; Zwezerijnen GJC; Heymans MW; Pieplenbosch S; Wiegers SE; Dührsen U; Hüttmann A; Kurch L; Hanoun C; Lugtenburg PJ; Barrington SF; Mikhaeel NG; Ceriani L; Zucca E; Czibor S; Györke T; Chamuleau MED; Hoekstra OS; de Vet HCW; Boellaard R; Zijlstra JM
    Blood; 2023 Jun; 141(25):3055-3064. PubMed ID: 37001036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Values of Different Evaluation Criteria of Interim
    Zhu LT; Cen XN; Ou JP; Qiu ZX; Wang LH; Liu W; Wang WS; Dong YJ; Liang ZY; Wang MJ; Xu WL; Sun YH; Wang Q; Yin Y; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):431-437. PubMed ID: 28446288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with
    Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal deep learning model on interim [
    Yuan C; Shi Q; Huang X; Wang L; He Y; Li B; Zhao W; Qian D
    Eur Radiol; 2023 Jan; 33(1):77-88. PubMed ID: 36029345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of
    Michaud L; Bantilan K; Mauguen A; Moskowitz CH; Zelenetz AD; Schöder H
    J Nucl Med; 2023 Apr; 64(4):536-541. PubMed ID: 36549918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.
    Zhou M; Chen Y; Huang H; Zhou X; Liu J; Huang G
    Oncotarget; 2016 Dec; 7(50):83544-83553. PubMed ID: 27835875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trial.
    Broecker-Preuss M; Becher-Boveleth N; Müller SP; Hüttmann A; Hanoun C; Grafe H; Richter J; Klapper W; Rekowski J; Bockisch A; Dührsen U
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2611-2621. PubMed ID: 34708297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum level of soluble interleukin-2 receptor is positively correlated with metabolic tumor volume on
    Senjo H; Kanaya M; Izumiyama K; Minauchi K; Hirata K; Mori A; Saito M; Tanaka M; Iijima H; Tsukamoto E; Itoh K; Ota S; Morioka M; Hashimoto D; Teshima T;
    Cancer Med; 2019 Mar; 8(3):953-962. PubMed ID: 30790452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of negative interim 2-[¹⁸F]-fluoro-2-deoxy-d-glucose PET/CT in diffuse large B-cell lymphoma.
    Kwon SH; Kang DR; Kim J; Yoon JK; Lee SJ; Jeong SH; Lee HW; An YS
    Clin Radiol; 2016 Mar; 71(3):280-6. PubMed ID: 26732889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.